Login -
Region: North America
         

VELA Diagnostics

Skip navigation
  • Home
  • Solutions
    • Next-Generation Sequencing
    • Near-Patient Testing
    • Real-Time PCR
    • Sentosa FLEX
    • Pharma Partnering
  • Products
    • Laboratory Testing
      • NGS
      • PCR
      • Labware
      • Consumables
    • Near-Patient Testing
    • Symbol Glossary
  • Instruments & Systems
    • NGS Instruments
      • SX101
      • SQ301
      • ST401
    • PCR Instruments and Systems
      • SA201
      • SX101
      • RGQ
      • GB Analyzer
  • Support
    • Technical Support
    • Order Management
  • Company
    • At a Glance
    • Corporate Values
    • Management Team
    • Careers
    • Contact
      • Contact Form
      • Global Distributors
  • Newsroom
    • Press Releases
    • Events
    • Multimedia
      • Reference Lab Seminar
      • KOL Seminar
      • Webinars
    • Publications
  • Blog
 
Skip navigation
  • Home
  • Solutions
    • Next-Generation Sequencing
    • Near-Patient Testing
    • Real-Time PCR
    • Sentosa FLEX
    • Pharma Partnering
  • Products
    • Laboratory Testing
      • NGS
      • PCR
      • Labware
      • Consumables
    • Near-Patient Testing
    • Symbol Glossary
  • Instruments & Systems
    • NGS Instruments
      • SX101
      • SQ301
      • ST401
    • PCR Instruments and Systems
      • SA201
      • SX101
      • RGQ
      • GB Analyzer
  • Support
    • Technical Support
    • Order Management
  • Company
    • At a Glance
    • Corporate Values
    • Management Team
    • Careers
    • Contact
      • Contact Form
      • Global Distributors
  • Newsroom
    • Press Releases
    • Events
    • Multimedia
      • Reference Lab Seminar
      • KOL Seminar
      • Webinars
    • Publications
  • Blog
 
Skip navigation
  • PCR
    • Tests
      • Zoonotic Diseases
        • MPXV
      • Microbiology
        • Direct MRSA/SA
        • UTI ID & AMR
      • Human Herpes and Polyomaviruses
        • BKV Quant
        • CMV Quant
        • EBV Quant
        • HSV-1/2 Quant
        • HSV-1/2 Qual
        • VZV Quant
        • ISP FLEX
        • HHV6 Quant
      • Leukemia
        • BCR-ABL(M)Qt
        • BCR-ABL(m)Qt
      • Respiratory Viruses
        • Influenza A/B & RSV
        • SARS-CoV-2 v2.0
        • SARS-CoV-2 ID
        • Flu/RSV/SARS-CoV-2
    • Instruments
      • RGQ
      • SA201
      • SX101
    • Software
      • SA Reporter
      • SA201 Reporter
    • Extraction Kits
      • Total RNA
      • Virus Total NA
      • Virus Total NA Plus
      • Whole Blood
  • NGS
    • Tests
      • Oncology
        • NSCLC
        • OncoKey Core
        • OncoKey Focus
        • Leukemia
        • OncoKey Hereditary
      • Virology
        • HCV GT v2.0
        • HIV-1
        • HIV/HCV/HBV/CMV FLEX
        • SARS-CoV-2 FLEX
      • Microbiology
        • Pathogen ID
    • Library Preparation
      • Fragm Library Prep
    • Template Preparation / Sequencing
      • 318 Chip
      • Sequencing Kit
      • Template Kit
    • Instruments
      • SX101
      • SQ301
      • ST401
    • Software
      • SQ Reporter
  • Labware
  • Consumables
  • Symbol Glossary
 
  • Global Provider of Integrated PCR & NGS Solutions ...
  • »
  • Newsroom
  • »
  • Press Releases - Archive

Press Releases - Archive

Please select a year:

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

2014

November 12, 2014

Vela Diagnostics Announces the Listing of their Next-Generation Sequencing System with the U.S. FDA as a Class II Medical Device

Read more >

October 22, 2014

Vela Diagnostics Announces Availability of Non-Small Cell Lung Cancer (NSCLC) and Colorectal Cancer (CRC) Next-Generation Sequencing Panels for Early Access Customers

Read more >

October 15, 2014

Vela Diagnostics Announces Availability of HCV Genotyping Next-Generation Sequencing Assay for Early Access Customers

Read more >

October 14, 2014

Vela Diagnostics Launched Combined PCR and NGS workflow

Read more >

September 22, 2014

Vela Diagnostics Launches First CE-IVD Next-Generation Sequencing Oncology Panel for Melanoma Testing on the Automated Sentosa NGS Workflow

Read more >

June 3, 2014

Vela Diagnostics Launches the Sentosa SA KRAS PCR Test

Read more >

May 28, 2014

Vela Diagnostics Announces Pre-Launch of an Automated Next-Generation Sequencing (NGS) Solution

Read more >

May 19, 2014

Vela Diagnostics Launches the Sentosa® SA Direct MRSA/SA PCR Test

Read more >

January 23, 2014

Vela Diagnostics launches qualitative test to identify never before documented virus in Western hemisphere

Read more >

Skip navigation
  • Newsroom
 
Skip navigation
  • Press Releases
  • Events
  • Multimedia
    • Reference Lab Seminar
    • KOL Seminar
    • Webinars
  • Publications
 

qPCR Solutions
Next-Gen Sequencing Solutions
qPCR Tests
Next-Gen Sequencing Assays

Sentosa SX101
Rotor-Gene® Q MDx
Sentosa SQ301 Sequencer
Labware
Consumables

Press Releases
Events
Multimedia

At a Glance
Corporate Values
Management Team
Careers

Company
Support
Contact

Terms of Use  |  Personal Data Protection Statement  |  Sitemap |  Cookie Policy

 
 
 
 
 

© 2022 Vela Diagnostics

 
Disclaimer: All products listed here are by Vela Diagnostics. The products listed on this site are to be used by trained personnel only. All products are to be used only in accordance with local laws, regulations and package instructions. Not all products may be available in all countries. Please contact your local Vela Diagnostics representative for questions about product availability in your country. OncoKey®, PathoKey®, VELA® and ViroKey® are registered trademarks of Vela Diagnostics Holding Pte Ltd in several markets including the US, EU, PRC and the UK. Sentosa® is a registered trademark of Vela Diagnostics Holding Pte Ltd outside Singapore in several markets including the US, EU, PRC and the UK. All Sentosa® products mentioned above are by Vela Diagnostics. All other product names, trademarks and logos are the property of their respective owners.